EMCDDA Home
  • EN
Search

Figure GPS-18. Overview of drug prevalence estimates in Europe for all adults (aged 15–64) and young adults (aged 15–34)

Part (ii) Cocaine, amphetamines and ecstasy use: lifetime experience, last 12 months and last 30 days prevalence

 
 
SubstanceBelgiumBulgariaCzech RepublicDenmarkGermanyEstoniaIrelandGreeceSpainFranceItalyCyprusLatviaLithuaniaLuxembourgHungaryMaltaNetherlandsAustriaPolandPortugalRomaniaSloveniaSlovakiaFinlandSwedenUK (England and Wales)CroatiaTurkeyNorwayEU average
Cocaine LTP All adults1.71.44.43.36.80.78.83.74.23.01.50.50.90.45.22.21.31.90.30.61.73.39.62.32.54.2
Cocaine LYP All adults0.90.70.60.90.80.71.50.12.30.90.61.20.20.20.20.31.20.90.70.60.10.20.20.52.20.50.41
Cocaine LMP All adults0.40.10.20.30.10.501.10.20.70.10.10.20.10.50.60.50.300.100.110.30.20.5
Amphetamines LTP All adults2.12.16.23.74.50.13.31.71.80.72.21.61.80.43.12.54.20.90.10.52.3511.52.60.33.83.7
Amphetamines LYP All adults0.90.80.70.71.10.400.60.20.10.30.30.70.500.40.51.90.200.10.80.80.80.80.70.6
Amphetamines LMP All adults0.500.30.30.50.100.300.20.10.20.300.20.20.90.1000.10.30.30.20.40.3
Ecstasy LTP All adults1.75.82.12.46.90.43.62.41.82.02.72.12.40.76.22.33.41.30.71.91.82.18.62.50.113.3
Ecstasy LYP All adults0.71.60.30.41.20.50.20.70.200.60.410.50.21.40.51.50.40.20.50.40.11.40.40.30.6
Ecstasy LMP All adults0.30.10.10.20.20.100.300.300.30.20.20.40.20.60.20.10.20.100.50.20.10.3
Cocaine LTP Young adults32.58.95.09.41.011.16.06.55.32.20.71.80.97.62.82.32.80.71.12.64.613.63.84.26.1
Cocaine LYP Young adults2.01.51.12.51.81.32.80.23.61.91.32.20.30.30.42.41.21.31.20.20.40.61.24.20.90.61.9
Cocaine LMP Young adults0.80.30.60.40.210.11.70.51.30.10.10.20.50.90.600.200.31.90.40.10.8
Amphetamines LTP Young adults4.43.910.35.46.40.24.62.42.21.23.52.54.00.75.13.18.21.30.11.24.35.712.45.10.46.05.5
Amphetamines LYP Young adults2.11.421.92.50.80.11.10.50.10.70.61.11.20.93.90.400.31.61.51.41.60.81.3
Amphetamines LMP Young adults1.100.60.91.300.10.500.30.20.50.31.80.2000.50.20.50.50.30.6
Ecstasy LTP Young adults3.69.75.85.0110.65.74.52.93.84.43.95.11.4123.36.52.60.93.53.93.712.24.60.12.15.7
Ecstasy LYP Young adults1.62.50.81.02.30.90.41.40.40.11.00.81.913.113.10.90.40.91.10.22.80.50.10.61.3
Ecstasy LMP Young adults0.70.30.20.30.50.100.600.50.10.60.30.510.40.30.40.201.10.20.100.5

Notes:

Data are from the most recent national surveys available in each country (see General population survey tables, Statistical bulletin 2013).

For each country, the average of the sample prevalences, weighted by sample size, is indicated by the highlighted data point

Sources:

Reitox national reports 2012, taken from population surveys, reports or scientific articles.

Substance Cocaine LTP All adults Cocaine LYP All adults Cocaine LMP All adults Amphetamines LTP All adults Amphetamines LYP All adults Amphetamines LMP All adults Ecstasy LTP All adults Ecstasy LYP All adults Ecstasy LMP All adults Cocaine LTP Young adults Cocaine LYP Young adults Cocaine LMP Young adults Amphetamines LTP Young adults Amphetamines LYP Young adults Amphetamines LMP Young adults Ecstasy LTP Young adults Ecstasy LYP Young adults Ecstasy LMP Young adults
Belgium   0.9                 2.0              
Bulgaria 1.7 0.7 0.4 2.1 0.9 0.5 1.7 0.7 0.3 3 1.5 0.8 4.4 2.1 1.1 3.6 1.6 0.7
Czech Republic 1.4 0.6 0.1 2.1 0.8 0 5.8 1.6 0.1 2.5 1.1 0.3 3.9 1.4 0 9.7 2.5 0.3
Denmark 4.4 0.9 0.2 6.2 0.7 0.3 2.1 0.3 0.1 8.9 2.5 0.6 10.3 2 0.6 5.8 0.8 0.2
Germany 3.3 0.8 0.3 3.7 0.7 0.3 2.4 0.4 0.2 5.0 1.8 0.4 5.4 1.9 0.9 5.0 1.0 0.3
Estonia   0.7 0.1   1.1 0.5   1.2 0.2   1.3 0.2   2.5 1.3   2.3 0.5
Ireland 6.8 1.5 0.5 4.5 0.4 0.1 6.9 0.5 0.1 9.4 2.8 1 6.4 0.8 0 11 0.9 0.1
Greece 0.7 0.1 0 0.1 0 0 0.4 0.2 0 1.0 0.2 0.1 0.2 0.1 0.1 0.6 0.4 0
Spain 8.8 2.3 1.1 3.3 0.6 0.3 3.6 0.7 0.3 ### 3.6 1.7 4.6 1.1 0.5 5.7 1.4 0.6
France 3.7 0.9   1.7 0.2   2.4 0.2   6.0 1.9   2.4 0.5   4.5 0.4  
Italy 4.2 0.6 0.2 1.8 0.1 0 1.8 0 0 6.5 1.3 0.5 2.2 0.1 0 2.9 0.1 0
Cyprus 3.0 1.2 0.7 0.7 0.3 0.2 2.0 0.6 0.3 5.3 2.2 1.3 1.2 0.7 0.3 3.8 1.0 0.5
Latvia 1.5 0.2 0.1 2.2 0.3 0.1 2.7 0.4 0 2.2 0.3 0.1 3.5 0.6 0.2 4.4 0.8 0.1
Lithuania 0.5 0.2 0.1 1.6 0.7 0.2 2.1 1 0.3 0.7 0.3 0.1 2.5 1.1   3.9 1.9 0.6
Luxembourg                                    
Hungary 0.9 0.2 0.2 1.8 0.5 0.3 2.4 0.5 0.2 1.8 0.4 0.2 4.0 1.2 0.5 5.1 1 0.3
Malta 0.4 0.3 0.1 0.4 0 0 0.7 0.2 0.2 0.9     0.7     1.4    
Netherlands 5.2 1.2 0.5 3.1 0.4 0.2 6.2 1.4 0.4 7.6 2.4   5.1     12 3.1  
Austria 2.2 0.9 0.6 2.5 0.5 0.2 2.3 0.5 0.2 2.8 1.2 0.5 3.1 0.9 0.3 3.3 1 0.5
Poland 1.3 0.7 0.5 4.2 1.9 0.9 3.4 1.5 0.6 2.3 1.3 0.9 8.2 3.9 1.8 6.5 3.1 1
Portugal 1.9 0.6 0.3 0.9 0.2 0.1 1.3 0.4 0.2 2.8 1.2 0.6 1.3 0.4 0.2 2.6 0.9 0.4
Romania 0.3 0.1 0 0.1 0 0 0.7 0.2 0.1 0.7 0.2 0 0.1 0 0 0.9 0.4 0.3
Slovenia                                    
Slovakia 0.6 0.2 0.1 0.5 0.1 0 1.9 0.5 0.2 1.1 0.4 0.2 1.2 0.3 0 3.5 0.9 0.4
Finland 1.7 0.2 0 2.3 0.8 0.1 1.8 0.4 0.1 2.6 0.6 0 4.3 1.6 0.5 3.9 1.1 0.2
Sweden 3.3 0.5 0.1 5 0.8 0.3 2.1 0.1 0 4.6 1.2 0.3 5.7 1.5 0.2 3.7 0.2 0
UK (England and Wales) 9.6 2.2 1 11.5 0.8 0.3 8.6 1.4 0.5 14 4.2 1.9 12 1.4 0.5 12 2.8 1.1
Croatia 2.3 0.5 0.3 2.6 0.8 0.2 2.5 0.4 0.2 3.8 0.9 0.4 5.1 1.6 0.5 4.6 0.5 0.2
Turkey       0.3     0.1           0.4     0.1 0.1 0.1
Norway 2.5 0.4 0.2 3.8 0.7 0.4 1 0.3 0.1 4.2 0.6 0.1 6.0 0.8 0.3 2.1 0.6 0
EU average 4.2 1 0.5 3.7 0.6 0.3 3.3 0.6 0.3 6.1 1.9 0.8 5.5 1.3 0.6 5.7 1.3 0.5

gpsfig18b

 

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Wednesday, 08 May 2013